Xeris Biopharma Holdings, Inc.
USD7.77
+0.03 (+0.40%)
CEO
John Shannon
IPO Date
2018-06-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$7.76
Prev. Close
$7.74
Day Low
$7.76
Day High
$7.81
52W Low
$4.52
52W High
$10.08
Market Cap
$1.34B
Volume
0.05M
| -9.1 |
| 31 Dec 2023 | FY | 82.5% | -38.0% | 917.9% | -19.3% | -33.79 | 1.64 | -5.2 |
| 31 Dec 2022 | FY | 79.5% | -85.9% | -209.5% | -27.5% | 4.38 | 2.54 | -1.9 |
| 31 Dec 2021 | FY | 73.1% | -247.5% | -128.9% | -40.3% | 0.92 | 1.80 | -1.9 |
| 31 Dec 2020 | FY | 54.4% | -446.0% | -270.0% | -57.3% | 2.58 | 5.40 | -2.3 |
| 31 Dec 2019 | FY | 41.1% | -4613.5% | -869.9% | -115.2% | 4.04 | 3.20 | -1.5 |
| 31 Dec 2018 | FY | 98.3% | -2437.3% | -79.7% | -50.1% | 0.42 | 11.59 | -3.4 |
| 31 Dec 2017 | FY | 99.7% | -1706.6% | 45.9% | -59.0% | 0.00 | 9.06 | -1.5 |
| 31 Dec 2016 | FY | 99.3% | -1228.7% | 41.4% | -39.4% | 0.00 | 13.13 | -2.8 |
| 29.4 |
| 30 Sept 2025 | Q3 | 85.2% | 0.8% | -72.1% | 0.2% | -44.35 | 1.93 | 582.0 |
| 30 Jun 2025 | Q2 | 79.6% | -2.7% | 10.0% | -0.6% | -13.32 | 1.95 | -94.4 |
| 31 Mar 2025 | Q1 | 85.5% | -15.3% | 26.2% | -2.9% | -7.65 | 1.72 | -22.7 |
| 31 Dec 2024 | Q4 | 84.2% | -8.5% | 17.3% | -1.6% | -9.17 | 1.67 | -24.7 |
| 30 Sept 2024 | Q3 | 75.0% | -29.0% | 55.6% | -4.9% | -9.57 | 1.79 | -6.7 |
| 30 Jun 2024 | Q2 | 78.2% | -31.2% | 77.8% | -4.5% | -13.99 | 2.26 | -5.4 |
| 31 Mar 2024 | Q1 | 85.3% | -46.7% | 206.8% | -5.6% | -29.28 | 2.37 | -4.0 |
| 31 Dec 2023 | Q4 | 76.8% | -30.2% | 197.4% | -4.2% | -33.79 | 1.64 | -6.1 |